vs
Side-by-side financial comparison of Kennedy-Wilson Holdings, Inc. (KW) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Kennedy-Wilson Holdings, Inc. is the larger business by last-quarter revenue ($120.6M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -11.0%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-55.2M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -6.0%).
Kennedy Wilson is a real estate investment company headquartered in Beverly Hills, California, United States.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
KW vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $120.6M | $75.5M |
| Net Profit | $58.0M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 57.3% | 22.7% |
| Net Margin | 48.1% | — |
| Revenue YoY | -11.0% | 27.7% |
| Net Profit YoY | 32.7% | — |
| EPS (diluted) | $0.22 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $120.6M | $75.5M | ||
| Q3 25 | $116.4M | $54.5M | ||
| Q2 25 | $135.7M | $52.4M | ||
| Q1 25 | $128.3M | $46.0M | ||
| Q4 24 | $135.5M | $59.1M | ||
| Q3 24 | $127.5M | $80.5M | ||
| Q2 24 | $132.0M | $47.1M | ||
| Q1 24 | $136.4M | $43.8M |
| Q4 25 | $58.0M | — | ||
| Q3 25 | $-10.2M | $8.8M | ||
| Q2 25 | $5.6M | $5.9M | ||
| Q1 25 | $-29.6M | $3.0M | ||
| Q4 24 | $43.7M | — | ||
| Q3 24 | $-66.8M | $20.3M | ||
| Q2 24 | $-48.3M | $-4.5M | ||
| Q1 24 | $37.7M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 57.3% | 22.7% | ||
| Q3 25 | -6.2% | 17.6% | ||
| Q2 25 | 7.4% | 12.7% | ||
| Q1 25 | -26.9% | 8.7% | ||
| Q4 24 | 36.7% | 22.6% | ||
| Q3 24 | -60.8% | 27.4% | ||
| Q2 24 | -45.5% | -4.6% | ||
| Q1 24 | 47.2% | -5.3% |
| Q4 25 | 48.1% | — | ||
| Q3 25 | -8.8% | 16.2% | ||
| Q2 25 | 4.1% | 11.2% | ||
| Q1 25 | -23.1% | 6.5% | ||
| Q4 24 | 32.3% | — | ||
| Q3 24 | -52.4% | 25.2% | ||
| Q2 24 | -36.6% | -9.6% | ||
| Q1 24 | 27.6% | -11.0% |
| Q4 25 | $0.22 | $0.26 | ||
| Q3 25 | $-0.15 | $0.17 | ||
| Q2 25 | $-0.05 | $0.12 | ||
| Q1 25 | $-0.30 | $0.06 | ||
| Q4 24 | $0.24 | $0.40 | ||
| Q3 24 | $-0.56 | $0.41 | ||
| Q2 24 | $-0.43 | $-0.09 | ||
| Q1 24 | $0.19 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $184.5M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $1.5B | $130.3M |
| Total Assets | $6.6B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $184.5M | $97.5M | ||
| Q3 25 | $382.6M | $94.4M | ||
| Q2 25 | $309.1M | $96.0M | ||
| Q1 25 | $356.6M | $93.2M | ||
| Q4 24 | $217.5M | $101.0M | ||
| Q3 24 | $367.1M | $96.7M | ||
| Q2 24 | $366.5M | $96.8M | ||
| Q1 24 | $541.9M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $1.5B | $130.3M | ||
| Q3 25 | $1.5B | $115.3M | ||
| Q2 25 | $1.6B | $104.7M | ||
| Q1 25 | $1.6B | $97.1M | ||
| Q4 24 | $1.6B | $92.1M | ||
| Q3 24 | $1.6B | $71.1M | ||
| Q2 24 | $1.7B | $48.5M | ||
| Q1 24 | $1.7B | $51.0M |
| Q4 25 | $6.6B | $216.3M | ||
| Q3 25 | $6.7B | $202.9M | ||
| Q2 25 | $6.8B | $194.9M | ||
| Q1 25 | $7.2B | $196.2M | ||
| Q4 24 | $7.0B | $213.3M | ||
| Q3 24 | $7.4B | $220.7M | ||
| Q2 24 | $7.5B | $205.0M | ||
| Q1 24 | $7.7B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.4M | $14.4M |
| Free Cash FlowOCF − Capex | $-55.2M | $14.4M |
| FCF MarginFCF / Revenue | -45.8% | 19.1% |
| Capex IntensityCapex / Revenue | 55.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.20× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-103.5M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.4M | $14.4M | ||
| Q3 25 | $-7.6M | $9.7M | ||
| Q2 25 | $42.0M | $14.1M | ||
| Q1 25 | $-51.9M | $3.6M | ||
| Q4 24 | $55.1M | $15.6M | ||
| Q3 24 | $-5.6M | $11.0M | ||
| Q2 24 | $36.7M | $1.0M | ||
| Q1 24 | $-5.6M | $11.2M |
| Q4 25 | $-55.2M | $14.4M | ||
| Q3 25 | $-18.0M | $9.7M | ||
| Q2 25 | $29.4M | $14.1M | ||
| Q1 25 | $-59.7M | $3.6M | ||
| Q4 24 | $-76.5M | $15.6M | ||
| Q3 24 | $-27.7M | $11.0M | ||
| Q2 24 | $-500.0K | $1.0M | ||
| Q1 24 | $-57.1M | — |
| Q4 25 | -45.8% | 19.1% | ||
| Q3 25 | -15.5% | 17.7% | ||
| Q2 25 | 21.7% | 26.8% | ||
| Q1 25 | -46.5% | 7.7% | ||
| Q4 24 | -56.5% | 26.4% | ||
| Q3 24 | -21.7% | 13.7% | ||
| Q2 24 | -0.4% | 2.1% | ||
| Q1 24 | -41.9% | — |
| Q4 25 | 55.2% | 0.0% | ||
| Q3 25 | 8.9% | 0.0% | ||
| Q2 25 | 9.3% | 0.0% | ||
| Q1 25 | 6.1% | 0.1% | ||
| Q4 24 | 97.1% | 0.0% | ||
| Q3 24 | 17.3% | 0.0% | ||
| Q2 24 | 28.2% | 0.0% | ||
| Q1 24 | 37.8% | 0.0% |
| Q4 25 | 0.20× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 7.50× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KW
| Consolidated Portfolio Segment | $84.9M | 70% |
| Investment Management Fees | $30.4M | 25% |
| Real Estate | $5.1M | 4% |
PBYI
Segment breakdown not available.
